Jefferies Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Jefferies Financial Group's IONS Position: Q3 2026 in Review
Jefferies Financial Group sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 38,665 shares — an estimated $3.07M sold.
Jefferies Financial Group first reported a position in IONS in Q4 2022 and held it in 14 quarters. The position peaked at $10.2M in Q4 2023. 285 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Jefferies Financial Group reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Jefferies Financial Group sold 38,665 Ionis Pharmaceuticals shares in Q3 2026, an estimated $3.07M.
- Jefferies Financial Group first reported a position in Ionis Pharmaceuticals in Q4 2022 and held it in 14 quarters.
- Jefferies Financial Group's Ionis Pharmaceuticals position peaked at $10.2M in Q4 2023.
- 285 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.